Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
3 CALLS ON FILE
BCAX
— Bicara Therapeutics Inc. Common Stock
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 11, 2026
REVENUE
$0
EPS
-$0.93
-36.8%
FREE CASH FLOW
-$37.6M
-55.7%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 3
OLDER CALL →